Compile Data Set for Download or QSAR
maximum 50k data
Found 9 Enz. Inhib. hit(s) with all data for entry = 6432
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128384(US8802721, 1)
Affinity DataIC50:  3nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128386(US8802721, 3)
Affinity DataIC50:  6.40nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128385(US8802721, 2)
Affinity DataIC50:  14nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128388(US8802721, 117)
Affinity DataIC50:  16.5nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128387(US8802721, 4)
Affinity DataIC50:  58.5nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128391(US8802721, 120)
Affinity DataIC50:  87nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128390(US8802721, 119)
Affinity DataIC50:  94.8nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128389(US8802721, 118)
Affinity DataIC50:  104nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Synta Pharmaceuticals

US Patent
LigandPNGBDBM128392(US8802721, 121)
Affinity DataIC50:  164nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent